Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance

Health coalitions in Ontario and Manitoba are calling for the end of Canadian Blood Services' contract with pharmaceutical corporation Grifols following reports of patient deaths, kidney damage, and multiple non-compliance findings at for-profit plasma collection centres across Canada. The coalitions are demanding full disclosure of contract terms, compliance reports, and adverse events, and are calling for expansion of the voluntary public blood donation system instead of for-profit plasma harvesting.

03/13/2026, 4:41 PM • GlobeNewswire

Blood Group Typing Global Market Overview 2025-2030: PCR-based Techniques Command the Largest Share

Global blood group typing market expected to grow from $2.4 billion in 2024 to $3.9 billion by 2030, driven by advancements in molecular technologies, increasing surgeries, and healthcare infrastructure expansion in emerging economies.

11/14/2025, 6:47 AM • GlobeNewswire

Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Distribution Channel, Route of Administration, and Region Analysis and Forecast to 2035

The global CIDP market is growing due to increased awareness, improved diagnostics, and demand for advanced treatments, with key players driving innovation in targeted biologic therapies despite challenges like high treatment costs and limited options for refractory cases.

08/11/2025, 5:48 AM • GlobeNewswire

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December

BioCryst Pharmaceuticals announced that Charlie Gayer will succeed Jon Stonehouse as CEO, effective January 1, 2026, after a successful commercial launch of ORLADEYO and driving significant revenue growth.

07/31/2025, 7:00 AM • GlobeNewswire